TickerFactsScreenerDevelopers

Skye Bioscience, Inc. (SKYE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$3.33M2018: -$3.94M2019: -$6.03M2020: -$6.05M2021: -$6.47M2022: -$12.74M2023: -$13.95M2024: -$25.24M2025: -$43.06M-$43.06M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$43.06M-70.6%
2024-$25.24M-80.9%
2023-$13.95M-9.5%
2022-$12.74M-96.8%
2021-$6.47M-6.9%
2020-$6.05M-0.4%
2019-$6.03M-52.9%
2018-$3.94M-18.4%
2017-$3.33M—